Glucocorticoids in the treatment of early and late RA.
Bijlsma
J W J
JW
Department of Rheumatology and Clinical Immunology (F02.127), University Medical Centre Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands. j.w.j.bijlsma@azu.nl
Boers
M
M
Saag
K G
KG
Furst
D E
DE
D000208:Acute Disease; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001424:Bacterial Infections / Q000209:etiology; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002386:Cataract / Q000139:chemically induced; D003072:Cognition Disorders / Q000139:chemically induced; D004357:Drug Synergism; D050723:Fractures, Bone / Q000517:prevention & control; D005901:Glaucoma / Q000139:chemically induced; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D013276:Stomach Ulcer / Q000139:chemically induced
D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D005938:Glucocorticoids